Company data
TG Therapeutics, Inc. employees and revenue per employee
TGTX · Biotechnology · $8.31B market cap
TG Therapeutics, Inc. had 399 employees at the end of fiscal Dec 2025, up 18.0% from a year earlier. Revenue for the year was $616M, up 87.3% from a year earlier, or $1.54M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
399
+18.0% YoY
Revenue
$616M
+87.3% YoY
Revenue / employee
$1.54M
Peer median $602K
Rank in industry
8 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 399 | $616M | $1.54M | +18.0% | +87.3% |
| Dec 2024 | 338 | $329M | $973K | +28.0% | +40.8% |
| Dec 2023 | 264 | $234M | $885K | +16.8% | +8290.0% |
| Dec 2022 | 226 | $2.8M | $12K | -21.0% | -58.4% |
| Dec 2021 | 286 | $6.7M | $23K | +5.1% | +4300.7% |
| Dec 2020 | 272 | $152,000 | $1K | +103.0% | +0.0% |
| Dec 2019 | 134 | $152,000 | $1K | +27.6% | +0.0% |
| Dec 2018 | 105 | $152,000 | $1K | +40.0% | -0.3% |
| Dec 2017 | 75 | $152,381 | $2K | +17.2% | +0.0% |
| Dec 2016 | 64 | $152,381 | $2K | — | — |
Open roles: we have not matched a verified job board for this company yet.
TG Therapeutics, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| ADMA ADMA Biologics, Inc. | 647 | $510M | $789K | Leaner |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| IONS Ionis Pharmaceuticals, Inc. | 1,402 | $944M | $673K | Efficient growth |
| BBIO BridgeBio Pharma, Inc. | 834 | $502M | $602K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| INSM Insmed Incorporated | 1,664 | $606M | $364K | Efficient growth |
Questions about TG Therapeutics, Inc.
- How many employees does TG Therapeutics, Inc. have?
- TG Therapeutics, Inc. reported 399 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is up 18.0% from a year earlier.
- What is TG Therapeutics, Inc.'s revenue per employee?
- TG Therapeutics, Inc. brought in $616M of revenue in fiscal Dec 2025, which is $1.54M per employee. That ranks 8 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare TGTX with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in TG Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell TGTX.